Search Items: Humans - immunology , . hits: 28
** Gerstmayr, M; Ilk, N; Schabussova, I; Jahn-Schmid, B; Egelseer, EM; Sleytr, UB; Ebner, C; Bohle, B A novel approach to specific allergy treatment: the recombinant allergen-S-layer fusion protein rSbsC-Bet v 1 matures dendritic cells that prime Th0/Th1 and IL-10-producing regulatory T cells..
** Schabussova, I; Amer, H; van Die, I; Kosma, P; Maizels, RM O-methylated glycans from Toxocara are specific targets for antibody binding in human and animal infections..
Int J Parasitol. 2007; 37(1):97-109 WoS PubMed FullText FullText_BOKU** Kopecky, EM; Greinstetter, S; Pabinger, I; Buchacher, A; Römisch, J; Jungbauer, A Effect of oriented or random PEGylation on bioactivity of a factor VIII inhibitor blocking peptide..
Biotechnol Bioeng. 2006; 93(4):647-655 WoS PubMed FullText FullText_BOKU** Haynes, BF; Fleming, J; St Clair, EW; Katinger, H; Stiegler, G; Kunert, R; Robinson, J; Scearce, RM; Plonk, K; Staats, HF; Ortel, TL; Liao, HX; Alam, SM Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies..
** Paschinger, K; Fabini, G; Schuster, D; Rendic, D; Wilson, IB Definition of immunogenic carbohydrate epitopes..
** Zwick, MB; Jensen, R; Church, S; Wang, M; Stiegler, G; Kunert, R; Katinger, H; Burton, DR Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1..
** Bencúrová, M; Hemmer, W; Focke-Tejkl, M; Wilson, IB; Altmann, F Specificity of IgG and IgE antibodies against plant and insect glycoprotein glycans determined with artificial glycoforms of human transferrin..
** Binley, JM; Wrin, T; Korber, B; Zwick, MB; Wang, M; Chappey, C; Stiegler, G; Kunert, R; Zolla-Pazner, S; Katinger, H; Petropoulos, CJ; Burton, DR Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies..
** Roux, KH; Zhu, P; Seavy, M; Katinger, H; Kunert, R; Seamon, V Electron microscopic and immunochemical analysis of the broadly neutralizing HIV-1-specific, anti-carbohydrate antibody, 2G12..
Mol Immunol. 2004; 41(10):1001-1011 WoS PubMed FullText FullText_BOKU** Zwick, MB; Komori, HK; Stanfield, RL; Church, S; Wang, M; Parren, PW; Kunert, R; Katinger, H; Wilson, IA; Burton, DR The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5..
** Calarese, DA; Scanlan, CN; Zwick, MB; Deechongkit, S; Mimura, Y; Kunert, R; Zhu, P; Wormald, MR; Stanfield, RL; Roux, KH; Kelly, JW; Rudd, PM; Dwek, RA; Katinger, H; Burton, DR; Wilson, IA Antibody domain exchange is an immunological solution to carbohydrate cluster recognition..
** Foetisch, K; Westphal, S; Lauer, I; Retzek, M; Altmann, F; Kolarich, D; Scheurer, S; Vieths, S Biological activity of IgE specific for cross-reactive carbohydrate determinants..
J Allergy Clin Immunol. 2003; 111(4):889-896 WoS PubMed FullText FullText_BOKU** Wolbank, S; Kunert, R; Stiegler, G; Katinger, H Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12..
** Armbruster, C; Stiegler, GM; Vcelar, BA; Jäger, W; Michael, NL; Vetter, N; Katinger, HW A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1..
AIDS. 2002; 16(2):227-233 WoS PubMed** Jursik, C; Voglauer, R; Grillari, J; Hemetsberger, T; Jungfer, H; Katinger, H Killer T cells: a promising new tool for adoptive immunotherapy..
Transplant Proc. 2002; 34(7):2879-2880 WoS PubMed** Kunert, RE; Weik, R; Ferko, B; Stiegler, G; Katinger, H Anti-idiotypic antibody Ab2/3H6 mimics the epitope of the neutralizing anti-HIV-1 monoclonal antibody 2F5..
AIDS. 2002; 16(4):667-668 WoS PubMed** Sanders, RW; Venturi, M; Schiffner, L; Kalyanaraman, R; Katinger, H; Lloyd, KO; Kwong, PD; Moore, JP The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120..
** Scanlan, CN; Pantophlet, R; Wormald, MR; Ollmann Saphire, E; Stanfield, R; Wilson, IA; Katinger, H; Dwek, RA; Rudd, PM; Burton, DR The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120..
** Hemmer, W; Focke, M; Kolarich, D; Wilson, IB; Altmann, F; Wöhrl, S; Götz, M; Jarisch, R Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy..
J Allergy Clin Immunol. 2001; 108(6):1045-1052 WoS PubMed FullText FullText_BOKU** Parker, CE; Deterding, LJ; Hager-Braun, C; Binley, JM; Schülke, N; Katinger, H; Moore, JP; Tomer, KB Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5..
** Petersen, A; Grobe, K; Schramm, G; Vieths, S; Altmann, F; Schlaak, M; Becker, WM Implications of the grass group I allergens on the sensitization and provocation process..
Int Arch Allergy Immunol. 1999; 118(2-4):411-413 WoS PubMed FullText FullText_BOKU** Kunert, R; Rüker, F; Katinger, H Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5..
AIDS Res Hum Retroviruses. 1998; 14(13):1115-1128 WoS PubMed** Purtscher, M; Trkola, A; Grassauer, A; Schulz, PM; Klima, A; Döpper, S; Gruber, G; Buchacher, A; Muster, T; Katinger, H Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5..
AIDS. 1996; 10(6):587-593 WoS PubMed** Trkola, A; Purtscher, M; Muster, T; Ballaun, C; Buchacher, A; Sullivan, N; Srinivasan, K; Sodroski, J; Moore, JP; Katinger, H Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1..
** Buchacher, A; Predl, R; Strutzenberger, K; Steinfellner, W; Trkola, A; Purtscher, M; Gruber, G; Tauer, C; Steindl, F; Jungbauer, A Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization..
AIDS Res Hum Retroviruses. 1994; 10(4):359-369 WoS PubMed** Tretter, V; Altmann, F; Kubelka, V; März, L; Becker, WM Fucose alpha 1,3-linked to the core region of glycoprotein N-glycans creates an important epitope for IgE from honeybee venom allergic individuals..
Int Arch Allergy Immunol. 1993; 102(3):259-266 WoS PubMed FullText FullText_BOKU** Jungbauer, A; Tauer, C; Wenisch, E; Steindl, F; Purtscher, M; Reiter, M; Unterluggauer, F; Buchacher, A; Uhl, K; Katinger, H Pilot scale production of a human monoclonal antibody against human immunodeficiency virus HIV-1..
J Biochem Biophys Methods. 1989; 19(2-3):223-240 WoS PubMed** Grunow, R; Jahn, S; Porstmann, T; Kiessig, SS; Steinkellner, H; Steindl, F; Mattanovich, D; Gürtler, L; Deinhardt, F; Katinger, H The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus..
J Immunol Methods. 1988; 106(2):257-265 WoS PubMed